Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patients
Global - North America
Archived
•
July 8, 2026
•
California-based company’s pill daraxonrasib doubles survival time for people with the deadly disease
Source: https://www.theglobeandmail.com/arc/outboundfeeds/rss/category/canada/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


